All News about Akero Therapeutics Inc
Analyst Ratings for Akero Therapeutics
June 07, 2023
Via Benzinga
Analyst Expectations for Akero Therapeutics's Future
June 07, 2023
Via Benzinga
From Akero Therapeutics
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via Benzinga
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
December 08, 2022
From Akero Therapeutics
Via GlobeNewswire
From Akero Therapeutics
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|